Business Forum • 25 July, 2025 at 1:01 PM
Italian pharmaceutical company Fidia Farmaceutici, specializing in regenerative medicine and the use of hyaluronic acid in advanced therapeutic applications, has purchased a majority stake in Meditrina Pharmaceuticals.
Meditrina Pharmaceuticals is a Romanian pharmaceutical distributor active in therapeutic areas such as dermatology, gynecology, urology, and nephrology.
“This is a strategic transaction and reflects investors' confidence in the potential of the local pharmaceutical sector,” says Liliana Busoiu, Partner at EY Parthenon Financial Diligence Leader, Romania.
EY Romania has provided financial and tax advisory services to Fidia Farmaceutici.
Tags: